Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
20,412,218
-
Share change
-
-837,733
-
Total reported value
-
$304,588,647
-
Put/Call ratio
-
0.75%
-
Price per share
-
$14.92
-
Number of holders
-
86
-
Value change
-
-$33,281,851
-
Number of buys
-
44
-
Number of sells
-
41
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2014
As of 31 Dec 2014,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,412,218 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FIRST MANHATTAN CO, BlackRock Fund Advisors, OPPENHEIMER FUNDS INC, State Street Corp, Foundation Asset Management, LP, BlackRock Institutional Trust Company, N.A., D. E. Shaw & Co., Inc., and ROYCE & ASSOCIATES LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.